UK robotic surgery group CMR Surgical has raised $165mn from existing investors including Japan’s SoftBank to fuel its global expansion as more surgeons embrace technology in operating theatres.
The UK’s largest private medtech company, CMR Surgical last raised money in 2021 with a $600mn injection at a valuation of $3bn. The valuation has not increased since then.
Robotic surgery has been growing steadily thanks to technological advances and rising demand for less invasive procedures. Robots can often perform surgery using smaller incisions than human surgeons.
Read the full story on the Financial Times here.